Mandate

Vinge advises Active Biotech on real estate transaction

March 14, 2019 M&A

Active Biotech AB (publ) has entered an agreement regarding sale of the property Forskaren 1 in Lund, to an investor collective led by the real estate company Estea AB. The purchase price amounts to SEK 275 million. The transaction is subject to the general meeting’s approval. 

Vinge advises Active Biotech. Vinge’s team is primarily composed of Erik Sjöman, Anna Edström, Christian Lindhé and Jessica Salomonsson. 

Related news

Vinge advises Ramirent in connection with its acquisition of JIAB

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.
March 21, 2023

Vinge has advised Svea Bank AB in connection with the issuance of Additional Tier 1 Capital of SEK 300 million

Vinge has advised Svea Bank AB (the “Company”) in connection with its issuance of additional tier 1 capital (AT1) of SEK 300 million to optimise its capital structure.
March 14, 2023

Vinge advises Anglo American in connection with investment in the Dannemora mine

Vinge has, together with Norton Rose Fulbright, advised Anglo American Limited in connection with entering into a royalty agreement of USD 10 million and a binding term sheet for an offtake agreement with Dannemora Iron AB. Moreover, Vinge has assisted with thereto related due diligence. Dannemora Iron AB is a wholly owned subsidiary of Grängesberg Exploration Holding AB (publ).
March 14, 2023